Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT02518490 · ClinicalTrials.gov registry record · NA

A Contralateral Dispensing Clinical Trial of Study Test Sapphire Lens Against Enfilcon A Silicone Hydrogel Lens

A NA study of Myopia, sponsored by CooperVision.

Completed
Registry status
NA
Development phase
18
Enrollment target
1
Study location

NCT02518490 is a NA study of Myopia that has completed, run by CooperVision. The registered enrollment target is 18 participants, below the 268-participant average among 90 other Myopia trials with a reported enrollment target (93% lower). The trial reports 1 study location across 1 state.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT02518490, a NA study of Myopia, has completed, sponsored by CooperVision.

COMPLETED
Registry status
NA
Development phase
18 participants
Enrollment target
1
Study location

Study Summary

This was be a randomized, contralateral, double-masked, dispensing study comparing the Study test lens against the control lens over one month of lens wear. The study results were not used for design validation of test lens.

Conditions Studied

Myopia

Interventions

  • DEVICE Sapphire Lens
  • DEVICE enfilcon A

Study Locations (1)

California

  • Clinical Research Center, University of California, Berkeley - Berkeley

Trial Details

FieldValue
Enrollment Target 18 participants
Start Date 2015-08
Est. Completion 2015-10
Phase NA

Sponsor

CooperVision

64 total trials

Interested in This Trial?

Full Details on ClinicalTrials.gov ↗

What the Registry Record Tells You About NCT02518490

The ClinicalTrials.gov registry entry for NCT02518490 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 18 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 268-participant average among 90 other Myopia trials with a reported enrollment target (93% lower). The listed sponsor is CooperVision, which has 64 total studies on file at ClinicalTrials.gov.

The record links to 1 condition, with Myopia appearing as the primary indexed condition, and to 2 interventions - of which Sapphire Lens is the first listed.

NCT02518490 reports 1 study location spanning 1 distinct geographic area - top geographies include California.

Frequently Asked Questions

What is clinical trial NCT02518490 about?

NCT02518490 is a clinical study titled "A Contralateral Dispensing Clinical Trial of Study Test Sapphire Lens Against Enfilcon A Silicone Hydrogel Lens". This was be a randomized, contralateral, double-masked, dispensing study comparing the Study test lens against the control lens over one month of lens wear. The study results were not used for design validation of test lens.

What is the current status of trial NCT02518490?

This trial is currently completed. It is a NA study. The enrollment target is 18 participants. The study started on 2015-08. Estimated completion is 2015-10.

What conditions does trial NCT02518490 study?

This clinical trial studies the following conditions: Myopia.

What interventions are being tested in trial NCT02518490?

The interventions under investigation include: Sapphire Lens (DEVICE), enfilcon A (DEVICE).

Who is sponsoring clinical trial NCT02518490?

This trial is sponsored by CooperVision, which has 64 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT02518490 being conducted?

This trial has 1 study location across California. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Learn More About Clinical Trials

Similar trials for Myopia

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Explore more on PlainTrial

Myopia

All registered trials for this condition

California

All trials with a study site in California

Recruiting now

Find trials open to new participants near you

Rankings

Top sponsors, conditions, and phases

Read our methodology - how this data is sourced, computed, and verified.

Related

Browse all → | Rankings →
Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial Editorial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.